Enhancing Vision


Launched at the 2012 ESCRS Congress, the AT LISA tri 839 MP is the first of a new generation of refractive-diffractive trifocal intraocular lenses designed to eliminate the middle-range trough in visual acuity seen with bifocal designs, said Ludwin Monz PhD, Carl Zeiss Meditec president and CEO. The lens splits incoming light 50 per cent to distance vision, 30 per cent to near and 20 per cent intermediate, and has high light transmittance. This helps maintain contrast sensitivity and range of vision, even in poor lighting, while reducing glare, haloes and other dysphotopsias. “The optics are very advanced,†Dr Monz said. It can be implanted through a 1.8mm incision. Zeiss also introduced PRESBYOND Laser Blended Vision. This corneal procedure increases the depth of field in both eyes, adjusting the dominant for intermediate to long vision and the non-dominant for near to intermediate. Overlap of the two fields in the intermediate range promotes fusion of the two images, making it a more flexible and tolerable alternative to conventional monovision. Astigmatism and other aberrations can also be corrected.
•  www.meditec.zeiss.com/escrsÂ
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.